{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
Status:
Investigational
Source:
USAN:SEVIPROTIMUT-L [USAN]
Source URL:
Class:
MIXTURE
Class:
MIXTURE
Status:
Investigational
Source:
NCT01530893: Not Applicable Interventional Completed Cardiovascular Disease Risk Reduction
(2012)
Source URL:
Class:
MIXTURE
Status:
Investigational
Source:
NCT03486990: Phase 2 Human clinical trial Completed N/A
Source URL:
Class:
MIXTURE
Status:
Investigational
Source:
NCT02018822: Not Applicable Interventional Completed Dental Caries
(2013)
Source URL:
Class:
MIXTURE
Status:
Investigational
Class:
MIXTURE
Status:
Investigational
Source:
INN:transferrin aldifitox [INN]
Source URL:
Class:
MIXTURE
Status:
Investigational
Source:
NCT02123940: Phase 3 Interventional Completed Adult Patients Ventilated More Than 48 h
(2014)
Source URL:
Class:
MIXTURE
Status:
Investigational
Source:
NCT02207478: Not Applicable Interventional Completed Lung Cancer
(2014)
Source URL:
Class:
MIXTURE
Status:
Investigational
Source:
NCT04670432: Phase 3 Interventional Active, not recruiting Deep Vein Thrombosis
(2020)
Source URL:
Class:
MIXTURE